Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGRGet Free Report) in a note issued to investors on Friday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of NASDAQ AVGR opened at $0.47 on Friday. Avinger has a 1 year low of $0.36 and a 1 year high of $4.37. The firm has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09. The stock has a fifty day moving average price of $0.48 and a two-hundred day moving average price of $0.68.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Recommended Stories

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.